India gov't seals deal for 300 mln Biological-E COVID-19 vaccine doses


Reuters | Bengaluru | Updated: 03-06-2021 08:47 IST | Created: 03-06-2021 08:47 IST
India gov't seals deal for 300 mln Biological-E COVID-19 vaccine doses
  • Country:
  • India

India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million).

The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement. ($1 = 72.9500 Indian rupees)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback